Psychedelics and Chronic Pain: What the Research Shows
Long-lasting pain that affects mood, sleep and daily life. Research summaries and safety screening; Gabriel doesn't give psychedelic dosing.
Overview
Chronic pain has physical and emotional sides that affect each other over time. Ketamine is used off-label by some pain specialists, and researchers are beginning to study classic psychedelics for pain.
This is early research, and results vary widely between people.
Substances Being Studied
Cannabis
StrongCannabis contains more than 100 cannabinoids; THC (tetrahydrocannabinol) and CBD (cannabidiol) are the most studied. Unlike classic psychedelics, cannabis works through the endocannabinoid system rather than serotonin receptors. THC causes euphoria, relaxation, altered perception and increased appetite, while CBD is not intoxicating. FDA has approved several cannabinoid medicines: Epidiolex, a CBD medicine, for certain seizure disorders, and dronabinol and nabilone for chemotherapy-related nausea and appetite loss. Researchers have studied cannabis for chronic pain, nausea, MS spasticity, sleep, PTSD, anxiety and appetite loss in cancer and HIV/AIDS; the evidence is strongest for chronic pain in adults, chemotherapy-related nausea and MS spasticity, and varies for the rest. Cannabis has been used medicinally in many cultures for thousands of years. Risks include dependence, cognitive effects with heavy use, anxiety or paranoia in some people, psychosis in vulnerable people, and lung irritation from smoking. Cannabis interacts with many medications, including blood thinners and seizure medicines, so tell your clinician and pharmacist if you use it.
Ketamine
StrongKetamine is a dissociative anesthetic that blocks NMDA receptors in the brain, which affects glutamate signaling and may help rebuild connections between nerve cells weakened by chronic stress and depression. Unlike classic psychedelics, it does not work mainly through serotonin receptors, and it can act within hours rather than weeks. Esketamine (Spravato), a nasal spray made from one form of ketamine, was FDA-approved in 2019 for treatment-resistant depression alongside an oral antidepressant, and in January 2025 as a treatment on its own; in the monotherapy trial, 22.5% of people on esketamine reached remission at four weeks versus 7.6% on placebo. Esketamine is given only in certified clinics, with monitoring after each dose. Racemic ketamine is not FDA-approved for any psychiatric condition; clinics that give IV ketamine for depression use it off-label. In October 2023, FDA warned about compounded ketamine for psychiatric use, including oral forms prescribed by telehealth for use at home, because no one monitors patients during treatment. During a supervised treatment, ketamine causes dissociation, altered time perception and dreamlike states that usually fade within an hour or two.
Peyote / Mescaline
TraditionalPeyote (Lophophora williamsii) is a small, spineless cactus containing mescaline as its primary psychoactive alkaloid. Sacred to the Native American Church (NAC), which has over 400,000 members across 50+ tribes, peyote serves as a holy sacrament in all-night ceremonies for spiritual communion, healing, and addressing personal and social imbalances. The NAC originated around 1885 among Kiowa and Comanche tribes, blending indigenous spirituality with Christian elements to preserve peyote traditions during persecution. Ceremonies occur in tipis around a crescent-shaped altar and sacred fire, running from Saturday evening through Sunday morning. Participants consume peyote (never smoked, only eaten dry, ground, or as tea) with prayer, singing, and contemplation, seeking guidance, healing, and communion with God and spirits. The Peyote Spirit is considered a deity providing visions, promoting brotherly love, family care, steady work, and abstinence from alcohol. Peyote contains more than 50 alkaloids; anthropologists have described sobriety as a goal of many Native American Church members, but controlled clinical research is minimal. Peyote is also a slow-growing, threatened cactus, and Native American Church leaders have asked non-Native people not to seek it out. The experience typically lasts 10-12 hours with enhanced perception, emotional openness, and spiritual insight.
San Pedro / Huachuma
TraditionalSan Pedro (Echinopsis pachanoi), known as Huachuma in indigenous traditions, is a mescaline-containing cactus native to the Andes mountains of Peru, Bolivia, Ecuador, and surrounding regions. With over 4,000 years of ceremonial use, it is one of the oldest entheogens in the Americas, predating psilocybin mushroom use. Archaeological evidence from Peru's Chavín culture (1500 BCE) shows stone carvings of shamans holding the cactus. The Inca used San Pedro in ceremonies at Cusco, Machu Picchu, and the Sacred Valley for spiritual communion with deities, purification, divination, healing, and governance counsel. The primary psychoactive compound, mescaline, increases prefrontal cortex activity for emotional regulation and planning while producing heart-opening, empathogenic effects alongside visual enhancements. Traditional curanderos (healers) in Peru and Ecuador use San Pedro tea in blended indigenous-modern medicine for shamanic healing, enhancing perception, awakening intuition, and diagnosing mind-body-spirit imbalances. The experience, lasting 10-14 hours, typically brings euphoria, compassion, empathy, enhanced environmental awareness, and insights into personal problems. Modern clinical research on mescaline is very limited, so these traditional uses have not been tested in controlled trials.
What the Research Shows
IV ketamine is used off-label by some pain specialists for certain chronic pain conditions, with mixed evidence. Research on psilocybin and other classic psychedelics for chronic pain is at an early stage, mostly small studies and surveys. As of October 2026, no psychedelic is FDA-approved for chronic pain.
Safety Considerations
- •Psychedelics can interact with pain medicines, including opioids. Never stop or change a prescribed medicine without your prescriber.
- •Results vary widely between individuals.
- •Should be part of a full pain care plan with a licensed clinician.
Safety screening
Psychedelics are not safe for everyone. Talk with a licensed clinician first, especially if any of these apply to you:
- Antidepressants such as SSRIs and SNRIs, and other medicines that raise serotonin (tramadol, for example): they can blunt the effect of psychedelics, and with some substances, such as MDMA and ayahuasca, raise the risk of serotonin syndrome.
- Lithium: seizures have been reported when lithium is combined with classic psychedelics such as psilocybin and LSD.
- MAOIs, including the MAOIs in ayahuasca: dangerous interactions with many medicines, other substances and some foods.
- Heart disease, high blood pressure, or a heart rhythm problem such as long QT syndrome.
- A personal or family history of psychosis, schizophrenia or bipolar disorder.
- Pregnancy or breastfeeding.
Never stop or change a prescribed medicine without your prescriber.
Gabriel doesn't give psychedelic dosing and doesn't help anyone obtain psychedelics. This page explains research and risks; it is not medical advice.
If you're in crisis, call or text 988 (Suicide and Crisis Lifeline). For a medical emergency, call 911.
Related Conditions
Questions? Ask Gabriel
Gabriel can help you find and book licensed clinicians who offer ketamine or esketamine treatment. Gabriel doesn't prescribe ketamine.
Ask Gabriel